Health and Healthcare

Pfizer : PFE

All Pfizer Articles

1490 Articles

Jon C. Ogg | Oct 28, 2013 at 1:19 PM EDT

Merck Sets Low Earnings Bar for Pfizer

The drug patent cliff for Big Pharma is coming with some continued consequences, and two drug giants with earnings this…

Douglas A. McIntyre | Oct 28, 2013 at 6:46 AM EDT

A New Rise in Global Mergers/Buyouts

courtesy of Verizon WirelessMergers and acquisitions (M&A) sometimes can be an excellent measure of the economy’s financial health. However, since…

Jon C. Ogg | Oct 27, 2013 at 8:38 AM EDT

The 10 Most Important Earnings in the Week Ahead

Jon OggEarnings season is in full swing and this coming week will bring many key earnings reports. This will also…

Jon C. Ogg | Oct 25, 2013 at 8:50 AM EDT

Short Sellers Abandoning Bets Against High-Yield Defensive Dividend Stocks

We have seen the short interest reports for the October 15 settlement date. It turns out that short sellers have…

Paul Ausick | Oct 10, 2013 at 10:20 AM EDT

High-Yield Dividend Stocks Face Rising Short Interest

ThinkstockShort sellers have increased their bets against the stable high-dividend stocks that are in most Americans’ retirement accounts and mutual…

Jon C. Ogg | Oct 9, 2013 at 8:15 AM EDT

Credit Suisse Major Drug Stocks to Buy for Great Gains Ahead

ThinkstockThe drug and pharmaceutical sector is supposed to be a defensive one by nature, even if this week’s government shutdown…

Jon C. Ogg | Oct 2, 2013 at 12:25 PM EDT

Spin-Offs Back in Vogue: Six Must-Watch Special Situations

ThinkstockWhen the markets go through periods of great gains, it is not uncommon to see companies start to take more…

Douglas A. McIntyre | Oct 2, 2013 at 6:30 AM EDT

Big Pharma and 100,000 Jobs at Risk

ThinkstockMerck & Co. (NYSE: MRK) announced it would rid itself of 8,500 workers, many of whom work in the big…

Jon C. Ogg | Sep 30, 2013 at 10:35 AM EDT

Five FDA Approvals and Reviews at Risk Under a Government Shutdown

via Wikimedia CommonsIt looks like Congress and the president still cannot figure out how to play well with each other,…

Jon C. Ogg | Sep 25, 2013 at 9:40 AM EDT

Short Sellers Pile On and Attack High-Yield Dividend Stocks

ThinkstockShort sellers have increased their bets against the stable high-dividend stocks that are in most Americans’ retirement accounts and mutual…

Jon C. Ogg | Sep 10, 2013 at 12:20 PM EDT

Intel, GE, Cisco, Pfizer and Microsoft Are About to Be Meaningless in the DJIA

Wikimedia CommonsChances are high that you already have heard that the Dow Jones Industrial Average (DJIA) is making a serious change…

Paul Ausick | Aug 16, 2013 at 4:06 PM EDT

Closing Bell for Friday on Wall Street: Markets Open Lower, Wobble to Weak Close

August 16, 2013: U.S. equity markets opened lower this morning following big down day on Thursday. In the U.S., the…

Paul Ausick | Aug 6, 2013 at 2:03 PM EDT

Can Facebook Become the Market’s Volume Leader?

Brian Solis, via Wikimedia CommonsOn the day that Facebook Inc. (NASDAQ: FB) came public last year, more than 580 million…

Paul Ausick | Jul 30, 2013 at 4:07 PM EDT

Closing Bell for Tuesday on Wall Street: Markets Open Higher, Drift to Mixed Close

July 30, 2013: U.S. equity markets opened higher this morning as traders and investors wait for tomorrow’s announcement from the…

Jon C. Ogg | Jul 29, 2013 at 3:28 PM EDT

Pfizer Restructuring May Precede Total Breakup of the Empire

Wikimedia CommonsWhenever you see huge restructurings and reclassifications for a major corporation, the first thing that should come to mind…

1 … 69 70 71 72 73 … 100

Pfizer : PFE

All Pfizer Articles

Merck Sets Low Earnings Bar for Pfizer

A New Rise in Global Mergers/Buyouts

The 10 Most Important Earnings in the Week Ahead

Short Sellers Abandoning Bets Against High-Yield Defensive Dividend Stocks

High-Yield Dividend Stocks Face Rising Short Interest

Credit Suisse Major Drug Stocks to Buy for Great Gains Ahead

Spin-Offs Back in Vogue: Six Must-Watch Special Situations

Big Pharma and 100,000 Jobs at Risk

Five FDA Approvals and Reviews at Risk Under a Government Shutdown

Short Sellers Pile On and Attack High-Yield Dividend Stocks

Intel, GE, Cisco, Pfizer and Microsoft Are About to Be Meaningless in the DJIA

Closing Bell for Friday on Wall Street: Markets Open Lower, Wobble to Weak Close

Can Facebook Become the Market’s Volume Leader?

Closing Bell for Tuesday on Wall Street: Markets Open Higher, Drift to Mixed Close

Pfizer Restructuring May Precede Total Breakup of the Empire

Why Is Institutional Money Pouring Into XRP ETFs While Fleeing Bitcoin and Ethereum?

U.S. Interest Expense Just Hit $1.6 Trillion Annually. Peter Schiff Warns a Dollar Crisis Arrives When It Hits $2 Trillion.

70-Year-Old Couple With $1.8M Just Got a Stage 2 Cancer Diagnosis. Financial Decisions They Have 60 Days to Make

70-Year-Old Couple With $1.8M Just Got a Stage 2 Cancer Diagnosis. Financial Decisions They Have 60 Days to Make

64-Year-Old Tech Exec Holds $1.6 Million in One Stock. The Wrong Move Could Cost $400,000.

Why Is Institutional Money Pouring Into XRP ETFs While Fleeing Bitcoin and Ethereum?

U.S. Interest Expense Just Hit $1.6 Trillion Annually. Peter Schiff Warns a Dollar Crisis Arrives When It Hits $2 Trillion.

Pfizer : PFE

All Pfizer Articles

Merck Sets Low Earnings Bar for Pfizer

A New Rise in Global Mergers/Buyouts

The 10 Most Important Earnings in the Week Ahead

Short Sellers Abandoning Bets Against High-Yield Defensive Dividend Stocks

High-Yield Dividend Stocks Face Rising Short Interest

Credit Suisse Major Drug Stocks to Buy for Great Gains Ahead

Spin-Offs Back in Vogue: Six Must-Watch Special Situations

Big Pharma and 100,000 Jobs at Risk

Five FDA Approvals and Reviews at Risk Under a Government Shutdown

Short Sellers Pile On and Attack High-Yield Dividend Stocks

Intel, GE, Cisco, Pfizer and Microsoft Are About to Be Meaningless in the DJIA

Closing Bell for Friday on Wall Street: Markets Open Lower, Wobble to Weak Close

Can Facebook Become the Market’s Volume Leader?

Closing Bell for Tuesday on Wall Street: Markets Open Higher, Drift to Mixed Close

Pfizer Restructuring May Precede Total Breakup of the Empire

Why Is Institutional Money Pouring Into XRP ETFs While Fleeing Bitcoin and Ethereum?

U.S. Interest Expense Just Hit $1.6 Trillion Annually. Peter Schiff Warns a Dollar Crisis Arrives When It Hits $2 Trillion.

70-Year-Old Couple With $1.8M Just Got a Stage 2 Cancer Diagnosis. Financial Decisions They Have 60 Days to Make

Featured Reads

70-Year-Old Couple With $1.8M Just Got a Stage 2 Cancer Diagnosis. Financial Decisions They Have 60 Days to Make

64-Year-Old Tech Exec Holds $1.6 Million in One Stock. The Wrong Move Could Cost $400,000.